Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer – Authors' reply

Research output: Contribution to journalComment/debateResearch

Original languageEnglish
JournalThe Lancet Oncology
Volume21
Issue number11
Pages (from-to)e516
Number of pages1
ISSN1470-2045
DOIs
Publication statusPublished - 1 Nov 2020

ID: 260747382